Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses - PubMed (original) (raw)
Comparative Study
. 1999 Spring;3(3):140-6.
doi: 10.1016/s1201-9712(99)90035-8.
Affiliations
- PMID: 10460925
- DOI: 10.1016/s1201-9712(99)90035-8
Free article
Comparative Study
Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses
E Bergfors et al. Int J Infect Dis. 1999 Spring.
Free article
Abstract
Objectives: To compare the incidence, clinical course, and serologic response to Bordetella antigens in patients with parapertussis and pertussis.
Design: Two studies were performed in Sweden during the 1990s, when pertussis vaccines were used only in clinical trials. Study I was a retrospective study of patients with positive Bordetella cultures obtained in clinical routine, and study II involved an active search for patients with Bordetella infections during a placebo-controlled trial of a pertussis toxoid vaccine.
Results: Study I includes 58, and study II 23 patients with parapertussis. In study I, the incidence of parapertussis was 0.016 cases per 100 person years in children 0 to 6 years old and 0 in older children and adults. In study II, the incidence rates of parapertussis and pertussis were 0.2 and 16.2 per 100 person years, respectively, in children followed from 3 months to 3 years of age. The median number of days with cough was 21 in parapertussis and 59 in pertussis. The proportions of children with whooping and vomiting were lower in parapertussis than in pertussis. Geometric mean serum filamentous hemagglutinin IgG increased from 6 to 63, and pertactin IgG from 4 to 12 units/mL in parapertussis patients, which was similar to increases in children with pertussis.
Conclusions: Disease caused by Bordetella parapertussis is diagnosed less commonly and is milder and of shorter duration than disease caused by Bordetella pertussis. Parapertussis induced serum IgG against filamentous hemagglutinin and pertactin of similar magnitude as does pertussis, and did not induce serum IgG against pertussis toxin.
Similar articles
- Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection.
He Q, Edelman K, Arvilommi H, Mertsola J. He Q, et al. Eur J Clin Microbiol Infect Dis. 1996 Oct;15(10):793-8. doi: 10.1007/BF01701521. Eur J Clin Microbiol Infect Dis. 1996. PMID: 8950556 - Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.
Isacson J, Trollfors B, Taranger J, Lagergård T. Isacson J, et al. Pediatr Infect Dis J. 1995 Jun;14(6):517-21. doi: 10.1097/00006454-199506000-00009. Pediatr Infect Dis J. 1995. PMID: 7667057 - Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
Watanabe M, Nagai M. Watanabe M, et al. Infect Immun. 2001 Nov;69(11):6981-6. doi: 10.1128/IAI.69.11.6981-6986.2001. Infect Immun. 2001. PMID: 11598073 Free PMC article. - Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.
Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergård T, Schneerson R, Robbins JB. Taranger J, et al. Pediatrics. 2001 Dec;108(6):E115. doi: 10.1542/peds.108.6.e115. Pediatrics. 2001. PMID: 11731642 Review. - Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
Hegerle N, Guiso N. Hegerle N, et al. Expert Rev Vaccines. 2014 Sep;13(9):1135-46. doi: 10.1586/14760584.2014.932254. Epub 2014 Jun 23. Expert Rev Vaccines. 2014. PMID: 24953157 Review.
Cited by
- Pertussis Vaccines Scarcely Provide Protection against Bordetella parapertussis Infection in Children-A Systematic Review and Meta-Analysis.
Remesh AT, Alagarasu K, Jadhav S, Prabhakar M, Viswanathan R. Remesh AT, et al. Vaccines (Basel). 2024 Feb 28;12(3):253. doi: 10.3390/vaccines12030253. Vaccines (Basel). 2024. PMID: 38543887 Free PMC article. Review. - Bordetella Type III Secretion Injectosome and Effector Proteins.
Kamanova J. Kamanova J. Front Cell Infect Microbiol. 2020 Sep 4;10:466. doi: 10.3389/fcimb.2020.00466. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33014891 Free PMC article. Review. - Pertussis: Microbiology, Disease, Treatment, and Prevention.
Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Kilgore PE, et al. Clin Microbiol Rev. 2016 Jul;29(3):449-86. doi: 10.1128/CMR.00083-15. Clin Microbiol Rev. 2016. PMID: 27029594 Free PMC article. Review. - The pertussis enigma: reconciling epidemiology, immunology and evolution.
Domenech de Cellès M, Magpantay FM, King AA, Rohani P. Domenech de Cellès M, et al. Proc Biol Sci. 2016 Jan 13;283(1822):20152309. doi: 10.1098/rspb.2015.2309. Proc Biol Sci. 2016. PMID: 26763701 Free PMC article. Review. - Widespread Bordetella parapertussis Infections-Wisconsin, 2011-2012: Clinical and Epidemiologic Features and Antibiotic Use for Treatment and Prevention.
Koepke R, Bartholomew ML, Eickhoff JC, Ayele RA, Rodd D, Kuennen J, Rosekrans J, Warshauer DM, Conway JH, Davis JP. Koepke R, et al. Clin Infect Dis. 2015 Nov 1;61(9):1421-31. doi: 10.1093/cid/civ514. Epub 2015 Jun 25. Clin Infect Dis. 2015. PMID: 26113655 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources